Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alra Care is a healthcare company specializing in the development and commercialization of specialized skincare products for patients undergoing cancer treatments, such as radiation therapy and chemotherapy. Founded in 1987 by scientists, including a cancer survivor, the company's flagship product is the Alra Therapy Lotion, which was specifically formulated to alleviate radiation dermatitis and skin sensitivity without interfering with treatment. The company's product line also includes non-zinc deodorants and mild conditioning shampoos designed to be safe for immunocompromised or sensitive skin. Alra Care focuses on providing non-invasive, supportive care solutions that improve the quality of life for oncology patients by managing treatment-related side effects.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alra.